{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:55:11Z","timestamp":1759056911496},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T00:00:00Z","timestamp":1291248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00296-010-1637-5","type":"journal-article","created":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T09:51:13Z","timestamp":1291197073000},"page":"611-619","source":"Crossref","is-referenced-by-count":15,"title":["A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis"],"prefix":"10.1007","volume":"32","author":[{"given":"Vidya S.","family":"Limaye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Lester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Blumbergs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Roberts-Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,2]]},"reference":[{"issue":"3","key":"1637_CR1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1445-5994.2008.01822.x","volume":"39","author":"VS Limaye","year":"2009","unstructured":"Limaye VS, Blumbergs P, Roberts-Thomson PJ (2009) Idiopathic inflammatory myopathies. Intern Med J 39(3):179\u2013190","journal-title":"Intern Med J"},{"key":"1637_CR2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","volume":"28","author":"FL Mastaglia","year":"2002","unstructured":"Mastaglia FL, Phillips BA (2002) Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin North Am 28:723\u2013741","journal-title":"Rheum Dis Clin North Am"},{"key":"1637_CR3","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325:1487\u20131498","journal-title":"N Engl J Med"},{"key":"1637_CR4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"1637_CR5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","volume":"56","author":"A Bohan","year":"1977","unstructured":"Bohan A, Peter JB, Bowman RL, Pearson CM (1977) Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 56:255\u2013286","journal-title":"Medicine (Baltimore)"},{"key":"1637_CR6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1479-8077.2007.00266.x","volume":"10","author":"V Limaye","year":"2007","unstructured":"Limaye V, Blumbergs P, Scott G, Roberts-Thomson P (2007) The clinical features of dermatomyositis in a South Australian population. APLAR J Rheumatol 10:86\u201393","journal-title":"APLAR J Rheumatol"},{"issue":"4","key":"1637_CR7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","volume":"84","author":"Y Troyanov","year":"2005","unstructured":"Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Sen\u00e9cal JL (2005) Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 84(4):231\u2013249","journal-title":"Medicine (Baltimore)"},{"key":"1637_CR8","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/art.10358","volume":"46","author":"EA Shanim","year":"2002","unstructured":"Shanim EA, Rider LG, Pandey JP, O\u2019Hanlon TP, Jara LJ, Samayoa EA et al (2002) Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethno geographic influences in the genetics and clinical expression of myositis. Arthritis Rheum 46:1885\u20131893","journal-title":"Arthritis Rheum"},{"key":"1637_CR9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.bor.0000142339.24380.b7","volume":"16","author":"H Chinoy","year":"2004","unstructured":"Chinoy H, Ollier WE, Cooper RG (2004) Have recent immunogenetic investigations increased our understanding of disease mechanisms in the idiopathic inflammatory myopathies? Curr Opin Rheumatol 16:707\u2013713","journal-title":"Curr Opin Rheumatol"},{"key":"1637_CR10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2249.1994.tb06604.x","volume":"98","author":"MJ Garlepp","year":"1994","unstructured":"Garlepp MJ, Laing B, Zilko PJ, Ollier W, Mastaglia F (1994) HLA associations with inclusion body myositis. Clin Exp Immunol 98:40\u201345","journal-title":"Clin Exp Immunol"},{"key":"1637_CR11","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1212\/01.WNL.0000148588.15052.4C","volume":"63","author":"UA Badrising","year":"2004","unstructured":"Badrising UA, Schreuder GMT, Giphart MJ, Geleijns K, Verschuuren JJ, Wintzen AR et al (2004) Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis. Neurology 63:2396\u20132398","journal-title":"Neurology"},{"key":"1637_CR12","doi-asserted-by":"crossref","unstructured":"Lampe JB, Gossrau G, Kempe A, Fussel M, Schwurack K, Schroder R, et al. (2003) Analysis of HLA class I and II alleles in sporadic inclusion-body myositis. J Neurol 250:1313\u20131317","DOI":"10.1007\/s00415-003-0204-3"},{"key":"1637_CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1568-9972(01)00004-0","volume":"1","author":"G Candore","year":"2002","unstructured":"Candore G, Lio D, Colonna Romano G, Caruso C (2002) Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmun Rev 1:29\u201335","journal-title":"Autoimmun Rev"},{"key":"1637_CR14","doi-asserted-by":"crossref","first-page":"116S","DOI":"10.1038\/jid.1993.34","volume":"100","author":"IN Targoff","year":"1993","unstructured":"Targoff IN (1993) Humoral immunity in polymyositis\/dermatomyositis. J Invest Dermatol 100:116S\u2013123S","journal-title":"J Invest Dermatol"},{"key":"1637_CR15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08916930600622645","volume":"39","author":"A Ghirardello","year":"2006","unstructured":"Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Benod R, Briani C et al (2006) Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity 39:217\u2013221","journal-title":"Autoimmunity"},{"issue":"4","key":"1637_CR16","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2276","volume":"9","author":"M Koenig","year":"2007","unstructured":"Koenig M, Fritzler MJ, Targoff IN, Troyanov Y, Sen\u00e9cal JL (2007) Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther 9(4):R78","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"1637_CR17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/BOR.0b013e328313bff4","volume":"20","author":"H Gunawardena","year":"2008","unstructured":"Gunawardena H, Betteridge ZE, McHugh NJ (2008) Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis. Curr Opin Rheumatol 20(6):675\u2013680","journal-title":"Curr Opin Rheumatol"},{"key":"1637_CR18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH et al (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 70:360\u2013374","journal-title":"Medicine"},{"key":"1637_CR19","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/art.21883","volume":"54","author":"Y Yamasaki","year":"2006","unstructured":"Yamasaki Y, Yamada H, Nozaki T, Akaogi J, Nichols C, Lyons R et al (2006) Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis\/dermatomyositis. Arthritis Rheum 54:2004\u20132009","journal-title":"Arthritis Rheum"},{"key":"1637_CR20","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/art.22506","volume":"56","author":"M Hirakata","year":"2007","unstructured":"Hirakata M, Suwa A, Takada T, Sato S, Nagai S, Genth E et al (2007) Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum 56:1295\u20131303","journal-title":"Arthritis Rheum"},{"key":"1637_CR21","first-page":"599","volume":"2","author":"RM Bernstein","year":"1993","unstructured":"Bernstein RM (1993) Autoantibodies in myositis. Baillieres Clin Neurol 2:599\u2013615","journal-title":"Baillieres Clin Neurol"},{"key":"1637_CR22","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.molimm.2006.10.013","volume":"44","author":"DA Rhodes","year":"2007","unstructured":"Rhodes DA, Trowsdale J (2007) TRIM21 is a trimeric protein that binds IgG Fc via the B30.2 domain. Mol Immunol 44:2406\u20132414","journal-title":"Mol Immunol"},{"key":"1637_CR23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2249.1997.4081308.x","volume":"109","author":"SA Rutjes","year":"1997","unstructured":"Rutjes SA, Vree Egberts WTM, Jongen P, Van Den Hoogen F, Pruijin GJM, Van Venrooij WJ (1997) Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 109:32\u201340","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"1637_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.md.0000217525.82287.eb","volume":"85","author":"TP O\u2019Hanlon","year":"2006","unstructured":"O\u2019Hanlon TP, Carrick DM, Targoff IN, Arnett FC, Reveille JD, Carrington M et al (2006) Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and\u2013DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore) 85(2):111\u2013127","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"1637_CR25","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/art.1780390910","volume":"39","author":"FC Arnett","year":"1996","unstructured":"Arnett FC, Targoff IN, Mimori T, Goldstein R, Warner NB, Reveille JD (1996) Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum 39(9):1507\u20131518","journal-title":"Arthritis Rheum"},{"key":"1637_CR26","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/art.1780390521","volume":"39","author":"R Mierau","year":"1996","unstructured":"Mierau R, Dick T, Bartz-Bazzanella P, Keller E, Albert ED, Genth E (1996) Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain. Arthritis Rheum 39:868\u2013876","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1637_CR27","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/ard.2008.097162","volume":"68","author":"ZE Betteridge","year":"2009","unstructured":"Betteridge ZE, Gunawardena H, Chinoy H, North J, Ollier WER, Cooper RG, McHugh NJ (2009) Clinical and HLA-class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK adult-onset Caucasian myositis. Ann Rheum Dis 68(10):1621\u20131625","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1637_CR28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.22237","volume":"55","author":"A Selva-O\u2019Callaghan","year":"2006","unstructured":"Selva-O\u2019Callaghan A, Labrador-Horrillo M, Solans-Laque R, Simeon-Aznar CP, Mart\u00ednez-G\u00f3mez X, Vilardell-Tarr\u00e9s M (2006) Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum 55(5):791\u2013798","journal-title":"Arthritis Rheum"},{"key":"1637_CR29","first-page":"221","volume-title":"Structural and molecular basis of skeletal muscle diseases","author":"R Hohlfeld","year":"2002","unstructured":"Hohlfeld R (2002) Polymyositis and dermatomyositis. In: Karpati G (ed) Structural and molecular basis of skeletal muscle diseases. ISN Neuropath Press, Switzerland, pp 221\u2013227"},{"issue":"2","key":"1637_CR30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1086\/338688","volume":"70","author":"DJ Schaid","year":"2002","unstructured":"Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70(2):425\u2013434","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1637_CR31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1399-0039.2004.00310.x","volume":"64","author":"P Price","year":"2004","unstructured":"Price P, Santoso L, Mastaglia F, Garlepp M, Kok CC, Allcock R, Laing N (2004) Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3. Tissue Antigens 64(5):575\u2013580","journal-title":"Tissue Antigens"},{"key":"1637_CR32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-065X.1999.tb01398.x","volume":"167","author":"P Price","year":"1999","unstructured":"Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC et al (1999) The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological conditions. Immunol Rev 167:257\u2013274","journal-title":"Immunol Rev"},{"key":"1637_CR33","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.coi.2004.07.001","volume":"16","author":"G Hauptmann","year":"2004","unstructured":"Hauptmann G, Bahram S (2004) Genetics of the central MHC. Curr Opin Immunol 16:668\u2013672","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"1637_CR34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00377968","volume":"23","author":"MJ Garlepp","year":"1986","unstructured":"Garlepp MJ, Wilton AN, Dawkins RL, White PC (1986) Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes. Immunogenetics 23(2):100\u2013105","journal-title":"Immunogenetics"},{"issue":"6","key":"1637_CR35","first-page":"345","volume":"36","author":"MA Degli-Esposti","year":"1992","unstructured":"Degli-Esposti MA, Abraham LJ, McCann V, Spies T, Christiansen FT, Dawkins RL (1992) Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics 36(6):345\u2013356","journal-title":"Immunogenetics"},{"issue":"9","key":"1637_CR36","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/eji.1830260923","volume":"26","author":"R McManus","year":"1996","unstructured":"McManus R, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D (1996) TNF2, a polymorphism of the tumour necrosis-\u03b1 gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur J Immunol 26(9):2113\u20132118","journal-title":"Eur J Immunol"},{"key":"1637_CR37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0198-8859(01)00264-6","volume":"62","author":"D Lio","year":"2001","unstructured":"Lio D, Candore G, Colombo A, Colonna Romano G, Gervasi F, Marino V et al (2001) A genetically determined high setting of TNF-alpha influences immunological parameters of HLA-B8, DR3 positive subjects: implications for autoimmunity. Human Immunol 62:705\u2013713","journal-title":"Human Immunol"},{"key":"1637_CR38","unstructured":"Chinoy H, Salway F, John S, Fertig N, Tait BD, Oddis CV, et al. (2007) UK Adult Onset Myositis Immunogenetic Collaboration (AOMIC). Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies. Rheumatology (Oxford) 46(9):1411\u20131416"},{"issue":"3","key":"1637_CR39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4103\/0028-3886.43444","volume":"56","author":"FL Mastaglia","year":"2008","unstructured":"Mastaglia FL (2008) Inflammatory muscle diseases. Neurol India 56(3):263\u2013270","journal-title":"Neurol India"},{"issue":"4\u20135","key":"1637_CR40","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s10067-003-0715-4","volume":"22","author":"CT Derk","year":"2003","unstructured":"Derk CT, Vivino FB, Kenyon L, Mandel S (2003) Inclusion body myositis in connective tissue disorders: case report and review of the literature. Clin Rheumatol 22(4\u20135):324\u2013328","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1637_CR41","first-page":"579","volume":"2","author":"MJ Garlepp","year":"1993","unstructured":"Garlepp MJ (1993) Immunogenetics of inflammatory myopathies. Baillieres Clin Neurol 2(3):579\u2013597","journal-title":"Baillieres Clin Neurol"},{"key":"1637_CR42","doi-asserted-by":"crossref","unstructured":"De Vries RR, Huizinga TW, Toes RE (2005) Redefining the HLA and RA association: to be or not to be anti-CCP positive. J Autoimmun 25(Suppl):21\u201325","DOI":"10.1016\/j.jaut.2005.09.005"},{"issue":"1","key":"1637_CR43","first-page":"32","volume":"10","author":"A Kapitany","year":"2008","unstructured":"Kapitany A, Szab\u00f3 Z, Lakos G, Aleksza M, V\u00e9gv\u00e1ri A, So\u00f3s L et al (2008) Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis. Isr Med Assoc J 10(1):32\u201336","journal-title":"Isr Med Assoc J"},{"issue":"4","key":"1637_CR44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncprheum0760","volume":"4","author":"TL Suber","year":"2008","unstructured":"Suber TL, Casciola-Rosen L, Rosen A (2008) Mechanisms of disease: autoantigens as clues to the pathogenesis of myositis. Nat Clin Pract Rheumatol 4(4):201\u2013209","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"1","key":"1637_CR45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.autrev.2009.03.005","volume":"9","author":"J R\u00f6nnelid","year":"2009","unstructured":"R\u00f6nnelid J, Barbasso Helmers S, Storfors H, Grip K, R\u00f6nnblom L, Franck-Larsson K et al (2009) Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies. Autoimmun Rev 9(1):58\u201361","journal-title":"Autoimmun Rev"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1637-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-010-1637-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1637-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T18:21:46Z","timestamp":1559845306000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-010-1637-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,2]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1637"],"URL":"https:\/\/doi.org\/10.1007\/s00296-010-1637-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,2]]}}}